Longevity Health Holdings Inc (XAGE) Stock Price & News

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	425,86 k	472,98 k	391,76 k	395,99 k
Cost of goods sold	194,68 k	219,05 k	351,42 k	199,37 k
Cost of revenue	194,68 k	219,05 k	351,42 k	199,37 k
Research and development expenses	227,99 k	104,08 k	55,49 k	73,35 k
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1,48 m	2,42 m	1,49 m	873,00 k
Operating expense	1,73 m	2,54 m	1,57 m	959,69 k
Total operating expenses	1,92 m	2,76 m	1,92 m	1,16 m
Operating income	-1,49 m	-2,29 m	-1,53 m	-763,07 k
Other non operating income	7,30 k	150,61 k	860,00	89,00
EBT including unusual items	-1,43 m	-2,05 m	-1,43 m	-1,88 m
EBT excluding unusual items	-1,49 m	-2,14 m	-1,53 m	-765,13 k
Income tax expense	-	36,26 k	-	-
Effective tax rate	-	-1,77%	-	-
Other operating expenses	-	-	-	-
Net income	-1,43 m	-2,08 m	-1,43 m	-1,88 m
Net profit margin	-335,73%	-440,44%	-365,45%	-475,59%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-5,06 k	-5,60 k	-3,45 k	-2,15 k
Net interest expenses	-5,06 k	-5,60 k	-3,45 k	-2,15 k
Depreciation and amortization charges	16,27 k	16,27 k	15,04 k	13,34 k
EBITDA	-1,48 m	-2,27 m	-1,51 m	-749,73 k
Gain or loss from assets sale	-	-	-	-

Finance